GOEL DAVID E.
SEC CIK 1548144 · EDGAR
BoughtSold
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-12-15 | 2025-12-15 | ZNTL | Zentalis Pharmaceuticals, Inc. | GOEL DAVID E. | 10% | S - Sale | $1.33 | -7.50M | 6.46M | -54% | -$9.97M |
| DI | 2024-07-03 | 2024-07-01 | ALMS | ALUMIS INC. | GOEL DAVID E. | Dir, 10%, See Remarks | C - Cnv Deriv | — | +8.15M | 8.15M | New | — |
| DI | 2024-07-03 | 2024-07-01 | ALMS | ALUMIS INC. | GOEL DAVID E. | Dir, 10%, See Remarks | A - Grant | $16.00 | +2.50M | 10.65M | +31% | +$40.00M |
| DI | 2021-11-04 | 2021-11-02 | AURA | Aura Biosciences, Inc. | GOEL DAVID E. | 10% | C - Cnv Deriv | — | +2.33M | 2.33M | New | — |
| DI | 2021-11-04 | 2021-11-02 | AURA | Aura Biosciences, Inc. | GOEL DAVID E. | 10% | P - Purchase | $14.00 | +1.78M | 4.11M | +77% | +$24.99M |
Purchase Sale Sale after option exercise All abbreviations